Pharmaceutical Care of Ambulatory Elderly Diabetes Patients

Diabetes Mellitus Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01455727
• Other study ID #: 100B4022-100MID-08
• Status: Completed
• Phase: N/A
• First received: October 14, 2011
• Last updated: September 13, 2012
• Start date: August 2011

Study information

• Verified date: September 2012
• Source: Nantou Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Interventional

Clinical Trial Summary

This trial will try to perform pharmaceutical care on ambulatory elderly diabetes patients. To provide appropriate diabetes education administration, identify and resolve drug-related problems, assess the appropriateness of their medications, establish the mechanism of medication consultations. Each patient will be assessed by the MMSE(Mini-Mental State Examination) and GDS(Geriatric Depression Scale). The effectiveness of pharmacist's intervention will be assessed by lab data and some questionnaires.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. primary completion date: August 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years to 90 Years

Eligibility

Inclusion Criteria:

• Age 65 years or older

• A1c greater than or equal to 9.0

Exclusion Criteria:

• Not expected to live for the duration of the study

• Unwillingness to participate and attend pharmacist visits

• Unwillingness to participate the questionnaires(MMSE, GDS)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Other:
• Pharmaceutical care
The Pharmacist provided Pharmaceutical care on the ambulatory elderly Diabetes patients, provided recommendation to the physician and reffered the patients to other diabetes-care-team members, including the CDEs and dietitians.
• Usual care
Control patients received usual care directed by their physician.

Locations

Country	Name	City	State
Taiwan	Nantou Hospital	Nantou

Sponsors (1)

Lead Sponsor	Collaborator
Nantou Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hgb A1c change	baseline, second measurement during 3 to 6 month after baseline, and the last measurement during 9 to 12 month after baseline	12 month	No
Secondary	Mini-Mental State Examination(MMSE) Score change	baseline and the second test was performed after 3 month.	1 year	No
Secondary	Taiwan Geriatric Depression Scale(GDS) Score change	baseline and the second test was performed after 3 month.	1 year	No